Hepatitis B e antigen reactive can anyone tell?

Question

I would like to know about Hepatitis Be chronic and carrier treatment, is there is a cure, how can the virus be killed, how can you cure so it will reverse the transmission. Is there any financial assistance for those who can not afford a private treatmente. wiill the SSI pays for Diasability benefits?

thank you

Answer 1

Find, then Go to a Medical University Center that has a department devoted to Hepatitis.
Then check out the fnancial options available including Charity Care

Answer 2

There are several treatments for HBV (Hep B virus), some may be able to make the virus undetectable. Some treatments are for one year (Pegasys is a drug recently approved for HBV treatment; there are other meds such as encantavir, & lamivudine). You cannot reverse the transmission of the virus; once you have it, you have it. Many of the drug companies have patient assistance programs where they will either give you the medication or charge you on a sliding scale. You will have to check around your area to see if there are clinics or agencies that offer medical care. It is unlikely that you will get disability for HBV; many people have hep b or c and still work, even while on treatment. Best wishes to you.

Answer 3

There are currently several treatments for chronic hepatitis B that can increase a person's chance of clearing the infection. Treatments are available in the form of antivirals such as lamivudine and adefovir and immune system modulators such as interferon alpha (Uniferon). There are several other antivirals under investigation. Roughly, all of the currently available treatments, when used alone, are about equally efficacious. However, some individuals are much more likely to respond than others. It does not appear that combination therapy offers any advantages. In general, each works by reducing the viral load by several orders of magnitude thus helping a body's immune system clear the infection. Treatment strategies should be individualized by a doctor and patient. Considerations include the risks associated with each treatment, a person's likelihood of clearing the virus with treatment, a person's risk for developing complications of persistent infection, and development of viral resistance with some of the treatments. On March 29, 2005, the US Food and Drug Administration (FDA) approved Entecavir for the treatment of hepatitis B. On February 25, 2005, the EU Commission approved PEGASYS for the treatment of hepatitis B making it the first pegylated interferon to be approved for hepatitis B. On October 27, 2006 telbivudine gained FDA approval for chronic treatment of chronic hepatitis B. Its side effects profile is generally less than that of other anti-virals in comparison, especially lamivudine. It is marketed under the brand name Tyzeka in the US and Sebivo outside the US. It is already approved in Switzerland. Chronic carriers should be strongly encouraged to avoid consuming alcohol as it increases their risk for cirrhosis and hepatocellular carcinoma (liver cancer). Infants born to mothers known to carry hepatitis B can be treated with antibodies to the hepatitis B virus (hepatitis B immune globulin or HBIg). When given with the vaccine within twelve hours of birth, the risk of acquiring hepatitis B is reduced 95%. This treatment also allows a mother to safely breastfeed her child. An individual exposed to the virus who has never been vaccinated may be treated with HBIg immediately following the exposure. For instance, a health care worker accidentally stuck by a needle used in a hepatitis B carrier would qualify. Treatment must be soon after exposure, however.

Answer 4

at this time, there are no cures for chonic Hep B